Role of oral tetracyclines in preventing acneiform rash in patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review
{{output}}
Introduction: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the current first-line therapy for non-small cell lung cancer (NSCLC). Acneiform rash is a common adverse effect of this treatment, leadi... ...
